Drs. Liisa Selin and Anna Gil, in collaboration with Dr. Salerno, have made a groundbreaking discovery in the fight against long COVID and ME/CFS with the introduction of Inspiritol-an innovative treatment designed to restore immune function. Inspiritol specifically targets CD8 T cells, which play a critical role in immune health, offering new hope to those struggling with these debilitating conditions.
Key Insights:
- CD8 T cells in patients with long COVID and ME/CFS show significant dysfunction, contributing to symptoms like fatigue and cognitive impairment.
- Inspiritol, developed by Dr. Salerno, is proving effective in improving these symptoms and revitalizing CD8 T cell functionality.
- This breakthrough treatment is opening doors to better diagnosis and management, offering renewed hope to millions affected by long COVID and ME/CFS.
Stay tuned for more updates on this pioneering research that aims to improve the lives of millions.
For more information about Inspiritol and this breakthrough, click here.
INSPIRITOL HAS NOT BEEN APPROVED BY THE FDA.
Tags:
Posted in Conditions